Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of sitagliptin to shorten hematopoietic stem cell engraftment after autologous transplantation in multiple myeloma
2008-005042-23Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sitagliptin in multiple myeloma (MM), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Variation of serum CXCL12 concentration. Started Oct 2008; status: completed.
02
Drugs
sitagliptin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-005042-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005042-23.